{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:39:42Z","timestamp":1773722382293,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza University of Rome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.redox.2024.103243","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:36:45Z","timestamp":1718732205000},"page":"103243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["PAR level mediates the link between ROS and inflammatory response in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"75","author":[{"given":"Michele","family":"Zampieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsiaryna","family":"Karpach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Raguzzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Barchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia Agata","family":"Cimini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Dule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"De Matteis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Zardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Borro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gisella","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8988-2342","authenticated-orcid":false,"given":"Anna","family":"Reale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2024.103243_bib1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.redox.2024.103243_bib2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.redox.2024.103243_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","article-title":"Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?","volume":"52","author":"Evans","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2024.103243_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is type II diabetes mellitus a disease of the innate immune system?","volume":"41","author":"Pickup","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2024.103243_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2010.12.006","article-title":"Oxidative stress, insulin signaling, and diabetes","volume":"50","author":"Rains","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2024.103243_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.redox.2024.103243_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tibs.2009.12.003","article-title":"Toward a unified nomenclature for mammalian ADP-ribosyltransferases","volume":"35","author":"Hottiger","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.redox.2024.103243_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","article-title":"New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103243_bib9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.mam.2012.12.010","article-title":"Poly(ADP-ribose): PARadigms and PARadoxes","volume":"34","author":"B\u00fcrkle","year":"2013","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.redox.2024.103243_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103243_bib11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.molcel.2015.01.034","article-title":"Biology of poly(ADP-ribose) polymerases: the factotums of cell maintenance","volume":"58","author":"Bai","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2024.103243_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors","volume":"54","author":"Vir\u00e1g","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.redox.2024.103243_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/6535","article-title":"Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin","volume":"5","author":"Burkart","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2024.103243_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cmet.2012.06.016","article-title":"The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease","volume":"16","author":"Bai","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2024.103243_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2008.080019","article-title":"Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease","volume":"173","author":"Pacher","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.redox.2024.103243_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/83241","article-title":"Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation","volume":"7","author":"Garcia Soriano","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2024.103243_bib17","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00125-009-1435-3","article-title":"Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies","volume":"52","author":"Horv\u00e1th","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2024.103243_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00592-017-1013-y","article-title":"Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies","volume":"54","author":"Giorgi","year":"2017","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.redox.2024.103243_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1743253","article-title":"Oxidative-nitrative stress and poly (ADP-Ribose) polymerase activation 3 Years after pregnancy","volume":"2018","author":"Horv\u00e1th","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2024.103243_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13148-021-01099-1","article-title":"Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus","volume":"13","author":"Zampieri","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.redox.2024.103243_bib21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.biocel.2007.04.013","article-title":"Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase\/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy","volume":"39","author":"Adaikalakoteswari","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.redox.2024.103243_bib22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jdiacomp.2016.05.025","article-title":"The relationship between obstructive sleep apnea and intra-epidermal nerve fiber density, PARP activation and foot ulceration in patients with type 2 diabetes","volume":"30","author":"Altaf","year":"2016","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.redox.2024.103243_bib23","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/01.CIR.0000038365.78031.9C","article-title":"Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity","volume":"106","author":"Szabo","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2024.103243_bib24","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/ATVBAHA.120.314712","article-title":"Poly(ADP-Ribose) polymerase activity and coronary artery disease in type 2 diabetes mellitus: an observational and bidirectional mendelian randomization study","volume":"40","author":"Cui","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2024.103243_bib25","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1073\/pnas.1405158111","article-title":"Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis","volume":"111","author":"Andrabi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2024.103243_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.redox.2024.103243_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2024.103243_bib28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2024.103243_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010041","article-title":"Multifaceted role of PARP-1 in DNA repair and inflammation: pathological and therapeutic implications in cancer and non-cancer diseases","volume":"9","author":"Pazzaglia","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.redox.2024.103243_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920944116","article-title":"PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers","volume":"12","author":"Lee","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.redox.2024.103243_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajpath.2010.12.004","article-title":"Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases","volume":"178","author":"Ba","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.redox.2024.103243_bib32","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/db12-1374","article-title":"Enhanced NF-\u03baB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes","volume":"62","author":"Kassan","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2024.103243_bib33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejphar.2016.09.008","article-title":"PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals","volume":"791","author":"Zakaria","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2024.103243_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41419-019-2215-8","article-title":"Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via Stat1\/Runx2 axis","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2024.103243_bib35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11357-021-00347-9","article-title":"Ageing affects subtelomeric DNA methylation in blood cells from a large European population enrolled in the MARK-AGE study","volume":"43","author":"Bacalini","year":"2021","journal-title":"GeroScience"},{"key":"10.1016\/j.redox.2024.103243_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetimm.2018.06.013","article-title":"Assessment of Poly(ADP-ribose) Polymerase1 (PARP1) expression and activity in cells purified from blood and milk of dairy cattle","volume":"202","author":"De Matteis","year":"2018","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.redox.2024.103243_bib37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12917-018-1540-y","article-title":"Effect of prolonged submaximal exercise on serum oxidative stress biomarkers (d-ROMs, MDA, BAP) and oxidative stress index in endurance horses","volume":"14","author":"Brklja\u010da Bottegaro","year":"2018","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.redox.2024.103243_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.redox.2024.103243_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exphem.2011.11.005","article-title":"A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis","volume":"40","author":"Bacalini","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.redox.2024.103243_bib40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","author":"Baron","year":"1986","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.redox.2024.103243_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2307\/270723","article-title":"Asymptotic confidence intervals for indirect effects in structural equation models","volume":"13","author":"Sobel","year":"1982","journal-title":"Socio. Methodol."},{"key":"10.1016\/j.redox.2024.103243_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/270922","article-title":"Some new results on indirect effects and their standard errors in covariance structure models","volume":"16","author":"Sobel","year":"1986","journal-title":"Socio. Methodol."},{"key":"10.1016\/j.redox.2024.103243_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"10.1016\/j.redox.2024.103243_bib44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bph.13748","article-title":"Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases","volume":"175","author":"Berger","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2024.103243_bib45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diabetes.53.3.711","article-title":"Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy","volume":"53","author":"Obrosova","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2024.103243_bib46","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.2337\/diabetes.53.11.2960","article-title":"Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB","volume":"53","author":"Zheng","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2024.103243_bib47","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.2337\/db06-0147","article-title":"Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb\/db mice","volume":"55","author":"Szab\u00f3","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2024.103243_bib48","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00125-009-1304-0","article-title":"Rapid \u201cglycaemic swings\u201d induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus","volume":"52","author":"Horv\u00e1th","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2024.103243_bib49","doi-asserted-by":"crossref","first-page":"35618","DOI":"10.18632\/oncotarget.8343","article-title":"Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2024.103243_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102530","article-title":"FBXW7 alleviates hyperglycemia-induced endothelial oxidative stress injury via ROS and PARP inhibition","volume":"58","author":"Li","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103243_bib51","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2024.103243_bib52","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.3390\/cimb45080420","article-title":"Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications","volume":"45","author":"Caturano","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.redox.2024.103243_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091047","article-title":"The role of PARPs in inflammation-and metabolic-related diseases: molecular mechanisms and beyond","volume":"8","author":"Ke","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.redox.2024.103243_bib54","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1016\/j.febslet.2012.09.026","article-title":"Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes","volume":"586","author":"Bai","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2024.103243_bib55","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00210-017-1360-9","article-title":"PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis","volume":"390","author":"Zakaria","year":"2017","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.redox.2024.103243_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12070964","article-title":"PARPs and ADP-ribosylation in chronic inflammation: a focus on macrophages","volume":"12","author":"V Santinelli-Pestana","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.redox.2024.103243_bib57","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3945\/jn.108.102756","article-title":"Poly (ADP-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes","volume":"139","author":"Weseler","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.redox.2024.103243_bib58","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jvs.2005.12.059","article-title":"Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation","volume":"43","author":"Shrikhande","year":"2006","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.redox.2024.103243_bib59","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","article-title":"The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders","volume":"59","author":"Hassa","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2024.103243_bib60","doi-asserted-by":"crossref","first-page":"40450","DOI":"10.1074\/jbc.M507553200","article-title":"Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription","volume":"280","author":"Hassa","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.redox.2024.103243_bib61","article-title":"Host regulator PARP1 contributes to sex differences and immune responses in a mouse model of tuberculosis","volume":"4","author":"Krug","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.redox.2024.103243_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7308897","article-title":"Olaparib: a clinically applied PARP inhibitor protects from experimental crohn's disease and maintains barrier integrity by improving bioenergetics through rescuing glycolysis in colonic epithelial cells","volume":"2021","author":"Kov\u00e1cs","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2024.103243_bib63","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/gutjnl-2017-314241","article-title":"NAD metabolism fuels human and mouse intestinal inflammation","volume":"67","author":"Gerner","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.redox.2024.103243_bib64","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.1801107","article-title":"ARTD1 in myeloid cells controls the IL-12\/18-IFN-\u03b3 Axis in a model of sterile sepsis, chronic bacterial infection, and cancer","volume":"202","author":"Kunze","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2024.103243_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1101\/gad.183509.111","article-title":"On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1","volume":"26","author":"Luo","year":"2012","journal-title":"Genes Dev."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231724002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231724002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:43:53Z","timestamp":1724082233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231724002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":65,"alternative-id":["S2213231724002210"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2024.103243","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAR level mediates the link between ROS and inflammatory response in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2024.103243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103243"}}